Fiche centre
HagaZiekenhuis
The Hague — Netherlands
Essais liés3clinical trials
VilleThe Haguelocalisation
PaysNetherlandslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT03747159
Essais cliniques associés
3| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Rituximab | SEP | Phase 3 | NCT00004179 | Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma | COMPLETED |
| Dapagliflozin 10 mg/day (oral) | Maladie rénale chronique | Phase 3 | NCT05374291 | The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKD | ACTIVE_NOT_RECRUITING |
| Belimumab Injection | Lupus | Phase 3 | NCT03747159 | SynBioSe-2 — Synergetic B-cell Immunomodulation in SLE - 2nd Study. | COMPLETED |